Literature DB >> 21274383

T2* magnetic resonance imaging of the liver in thalassemic patients in Iran.

Farhad Zamani1, Sara Razmjou, Shahram Akhlaghpoor, Seyyedeh-Masoomeh Eslami, Azita Azarkeivan, Afsaneh Amiri.   

Abstract

AIM: To investigate the accuracy of T2*-weighted magnetic resonance imaging (MRI T2*) in the evaluation of iron overload in beta-thalassemia major patients.
METHODS: In this cross-sectional study, 210 patients with beta-thalassemia major having regular blood transfusions were consecutively enrolled. Serum ferritin levels were measured, and all patients underwent MRI T2* of the liver. Liver biopsy was performed in 53 patients at an interval of no longer than 3 mo after the MRI T2* in each patient. The amount of iron was assessed in both MRI T2* and liver biopsy specimens of each patient.
RESULTS: Patients' ages ranged from 8 to 54 years with a mean of 24.59 ± 8.5 years. Mean serum ferritin level was 1906 ± 1644 ng/mL. Liver biopsy showed a moderate negative correlation with liver MRI T2* (r = -0.573, P = 0.000) and a low positive correlation with ferritin level (r = 0.350, P = 0.001). Serum ferritin levels showed a moderate negative correlation with liver MRI T2* values (r = -0.586, P = 0.000).
CONCLUSION: Our study suggests that MRI T2* is a non-invasive, safe and reliable method for detecting iron load in patients with iron overload.

Entities:  

Keywords:  Ferritin; Iron overload; Liver; Major thalassemia; T2*-weighted magnetic resonance imaging

Mesh:

Substances:

Year:  2011        PMID: 21274383      PMCID: PMC3027020          DOI: 10.3748/wjg.v17.i4.522

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

Review 1.  Noninvasive measurement of iron: report of an NIDDK workshop.

Authors:  Gary M Brittenham; David G Badman
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

2.  Evaluation of iron overload in beta-thalassemia patients using magnetic resonance imaging.

Authors:  Vassilios Perifanis; Marina Economou; Athanassios Christoforides; Afrodite Koussi; Ioannis Tsitourides; Miranda Athanassiou-Metaxa
Journal:  Hemoglobin       Date:  2004-02       Impact factor: 0.849

3.  Hepatic pathology in relatives of patients with haemochromatosis.

Authors:  P J SCHEUER; R WILLIAMS; A R MUIR
Journal:  J Pathol Bacteriol       Date:  1962-07

4.  Assessment of cardiac and hepatic iron overload in thalassaemic patients by magnetic resonance: a four year observational study.

Authors:  Giancarlo Candini; Sara Lappi
Journal:  Pediatr Endocrinol Rev       Date:  2008-10

5.  Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens.

Authors:  Athanasios Christoforidis; Afroditi Haritandi; Ioanna Tsatra; Ioannis Tsitourides; Stavroula Karyda; Miranda Athanassiou-Metaxa
Journal:  Eur J Haematol       Date:  2006-09-28       Impact factor: 2.997

6.  Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.

Authors:  Athanasios Christoforidis; Afroditi Haritandi; Ioannis Tsitouridis; Ioanna Tsatra; Haido Tsantali; Stavroula Karyda; Athanasios S Dimitriadis; Miranda Athanassiou-Metaxa
Journal:  J Pediatr Hematol Oncol       Date:  2006-05       Impact factor: 1.289

Review 7.  T2* magnetic resonance and myocardial iron in thalassemia.

Authors:  Dudley J Pennell
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

8.  Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.

Authors:  Ersi Voskaridou; Maroussa Douskou; Evangelos Terpos; Ioannis Papassotiriou; Alexandra Stamoulakatou; Akis Ourailidis; Aphroditi Loutradi; Dimitris Loukopoulos
Journal:  Br J Haematol       Date:  2004-09       Impact factor: 6.998

9.  Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.

Authors:  P Mazza; R Giua; S De Marco; M G Bonetti; B Amurri; C Masi; G Lazzari; C Rizzo; M Cervellera; A Peluso
Journal:  Haematologica       Date:  1995 Sep-Oct       Impact factor: 9.941

Review 10.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21
View more
  11 in total

1.  Hepatic magnetic resonance imaging with T2* mapping of ovariectomized rats: correlation between iron overload and postmenopausal osteoporosis.

Authors:  Lingshan Chen; Zhengqiu Zhu; Xingui Peng; Yuancheng Wang; Yaling Wang; Min Chen; Qi Wang; Jiyang Jin
Journal:  Eur Radiol       Date:  2014-04-28       Impact factor: 5.315

2.  Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography.

Authors:  Hassan M Ghoz; Paul T Kröner; Fernando F Stancampiano; Andrew W Bowman; Prakash Vishnu; Michael G Heckman; Nancy N Diehl; Ethan McLeod; Naveed Nikpour; William C Palmer
Journal:  Quant Imaging Med Surg       Date:  2019-06

3.  Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.

Authors:  Zahra Majd; Sezaneh Haghpanah; Gholam Hossein Ajami; Sara Matin; Hamid Namazi; Marzieh Bardestani; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2015-04-25       Impact factor: 0.611

4.  Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis.

Authors:  Dan Wang; Tian-Wu Chen; Xiao-Ming Zhang; Jie Li; Nan-Lin Zeng; Li Li; Yu-Lian Tang; Yu-Cheng Huang; Rui Li; Fan Chen; Yan-Li Chen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

5.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

6.  Relationship between T2* magnetic resonance imaging-derived liver and heart iron content and serum ferritin levels in transfusion-dependent thalassemic children.

Authors:  Kiran Suthar; Vishnu Kumar Goyal; Pramod Sharma; Bindu Deopa; Pradeep Singh Rathore; Rama Krishan Bishnoi
Journal:  Asian J Transfus Sci       Date:  2018 Jan-Jun

7.  Jadenu® Substituting Exjade® in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles.

Authors:  Mohamed A Yassin; Ashraf T Soliman; Vincenzo De Sanctis; Radwa M Hussein; Randa Al-Okka; Nancy Kassem; Rula Ghasoub; Ahmed Basha; Abdulqadir J Nashwan; Ahmad M Adel
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

8.  Serum ferritin levels and irregular use of iron chelators predict liver iron load in patients with major beta thalassemia: a cross-sectional study.

Authors:  Soheila Sobhani; Farzaneh Rahmani; Maryam Rahmani; Marzieh Askari; Farzad Kompani
Journal:  Croat Med J       Date:  2019-10-31       Impact factor: 1.351

9.  Evaluation of Corneal Epithelial Thickness and Dry Eye Disease Tests in Thalassemic Adolescents.

Authors:  Weam Mohamed Ebeid; Mahmoud Adel Kenny; Tamer AbdelFattah Badran
Journal:  Clin Ophthalmol       Date:  2021-04-06

10.  Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia.

Authors:  A Eghbali; H Taherahmadi; M Shahbazi; B Bagheri; L Ebrahimi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.